Skip to main content
Betta Pharmaceuticals Co.,Ltd logo

Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings

Ticker · 300558 ISIN · CNE100002DD9 LEI · 8368009YF4Y6NC7HVB09 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2019-08-26 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300558

About Betta Pharmaceuticals Co.,Ltd

https://www.bettapharma.com

Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.

Recent filings

Filing Released Lang Actions
2019年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled '2019 年半年度报告摘要' which translates to '2019 Half-Year Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also discusses operational performance, R&D progress, strategic cooperation, and production updates. The presence of comprehensive financial figures and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is over 6,000 characters and contains substantive financial data, not just an announcement or summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report. H1 2019
2019-08-26 Chinese
2019年半年度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (335 characters) indicating that the company's 2019 half-year report has been published and is available on a regulatory website. It explicitly states that the full report and summary were disclosed on a specific date and directs investors to review it. There is no substantive financial data or detailed report content within this document itself. According to the 'MENU VS MEAL' rule, this is a report publication announcement rather than the report itself.
2019-08-26 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting policies. It details the background, the specific changes, the impact on financial statements, and approvals from the board, supervisory committee, and independent directors. It does not contain actual financial statements or detailed financial data but rather explains the policy change and related governance approvals. The document length is short (1644 characters), and it is an announcement rather than a full financial report. Therefore, it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2019-08-26 Chinese
关于公司募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's fundraising (募集资金) storage and usage situation for the period January to June 2019. It includes specifics on the amount raised, the use of funds, changes in investment projects, compliance with regulatory requirements, and approvals by the board. The content focuses on the management and actual use of raised capital, including project adjustments and financial figures related to fundraising. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is substantive and not merely an announcement or certification, and it is not a full annual or interim report. Therefore, the appropriate classification is CAP with high confidence.
2019-08-26 Chinese
2019年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2019 年半年度报告' which translates to '2019 Semi-Annual Report'. It contains detailed financial data, company business overview, management discussion and analysis, financial statements, and other comprehensive information typical of an interim or quarterly report. The report period is specified as January 1, 2019 to June 30, 2019, confirming it covers a half-year period. The length of the document is substantial (15,000 characters), and it includes actual financial figures and analysis rather than just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-26 Chinese
中国国际金融股份有限公司关于公司2019年上半年度跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2019年上半年度跟踪报告" which translates to "2019 First Half Year Tracking Report". It is issued by a sponsoring institution (中国国际金融股份有限公司) regarding 贝达药业股份有限公司. The content includes detailed oversight and review activities related to company disclosures, governance, fundraising supervision, and compliance with commitments by the company and shareholders. The document contains substantive information about the company's performance and compliance for the half-year period of 2019, including detailed tables and descriptions of the sponsor's work and findings. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial and operational report for a period shorter than a full fiscal year. The document is over 5,000 characters and contains actual substantive content, not just an announcement or certification. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2019
2019-08-26 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.